Showing results (31-40 of 51) with videos related to
Sort By:
Pageof 6
Biomed Research International|June 1, 2018
MicroRNA Expression Profiling in Psoriatic ArthritisAndrea Pelosi, Claudio Lunardi, Piera Filomena Fiore, et al.Journal of Immunology Research|June 1, 2018
Gene Expression Profiling in Behcet's Disease Indicates an Autoimmune Component in the Pathogenesis of the Disease and Opens New Avenues for Targeted TherapyAntonio Puccetti, Piera Filomena Fiore, Andrea Pelosi, et al.Plos One|May 17, 2014
Gene expression profiling in peripheral blood mononuclear cells of patients with common variable immunodeficiency: modulation of adaptive immune response following intravenous immunoglobulin therapyMarzia Dolcino, Giuseppe Patuzzo, Alessandro Barbieri, et al.Journal of Immunology Research|June 20, 2015
Characterization of CD30/CD30L(+) Cells in Peripheral Blood and Synovial Fluid of Patients with Rheumatoid ArthritisAlessandro Barbieri, Marzia Dolcino, Elisa Tinazzi, et al.Plos One|May 31, 2007
Endothelial cells' activation and apoptosis induced by a subset of antibodies against human cytomegalovirus: relevance to the pathogenesis of atherosclerosisClaudio Lunardi, Marzia Dolcino, Dimitri Peterlana, et al.Clinical Chemistry|March 20, 2002
Biochemical and genetic markers of iron status and the risk of coronary artery disease: an angiography-based studyClaudia Bozzini, Domenico Girelli, Elisa Tinazzi, et al.Autoimmunity Reviews|July 20, 2020
Pathogenesis of immune thrombocytopenia in common variable immunodeficiencyElisa Tinazzi, Nicola Osti, Ruggero Beri, et al.Frontiers in Plant Science|December 10, 2015
Plant-Derived Chimeric Virus Particles for the Diagnosis of Primary Sjögren SyndromeElisa Tinazzi, Matilde Merlin, Caterina Bason, et al.International Immunology|July 10, 2012
Antibodies against human cytomegalovirus late protein UL94 in the pathogenesis of scleroderma-like skin lesions in chronic graft-versus-host diseaseRocco Pastano, Chiara Dell'Agnola, Caterina Bason, et al.International Immunology|February 3, 2009
Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatmentElisa Tinazzi, Antonio Puccetti, Roberto Gerli, et al.Pageof 6